8-K: Wellgistics Health: CEO, COO, CFO Resign; Interim CFO Named

Wellgistics Health, Inc. announced the simultaneous resignations of its Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer, followed by the appointment of an interim Chief Financial Officer.

Summary

• Brian Norton resigned from his position as Chief Executive Officer, effective October 6, 2025, at 5:00 p.m. EST.
• Tony Madsen resigned from his position as Chief Operating Officer, effective October 6, 2025, at 8:00 p.m. EST.
• Mark DiSiena resigned from his position as Chief Financial Officer, effective October 6, 2025, at 5:00 p.m. EST.
• On October 7, 2025, Eric Sherb was appointed as the interim Chief Financial Officer by the board of directors.
• Mr. Sherb, age 38, is a CPA with 16 years of experience in accounting advisory, auditing, and mergers and acquisitions, having worked at PricewaterhouseCoopers, RBSM LLP, and CFGI.
• Since October 2018, Mr. Sherb has been a founder and owner of EMS Consulting Services, LLC, and has extensive experience in financial reporting and governance within capital markets, including IPOs, direct listings, SPAC, and de-SPAC transactions.
• He has served as CFO and provided financial consultancy services for several NASDAQ and OTC clients, most recently Scienture Holdings (NASDAQ: SCNX).
• The Company entered into a Consulting Agreement (IC Agreement) with EMS Consulting Services, Inc., an entity controlled by Mr. Sherb, on September 8, 2025, which was amended to reflect his interim CFO role.
• Under the IC Agreement, Mr. Sherb will be paid an hourly rate of $185 for CPA services and $80 for services related to bookkeeping or the controller team.

Sentiment

Score: 3

Explanation: The simultaneous resignation of the CEO, COO, and CFO is a highly negative event, indicating significant leadership instability and potential operational disruption. While an experienced interim CFO has been appointed, the abrupt nature of the departures outweighs this positive, creating substantial uncertainty for the company's future.

Positives

• The appointment of Eric Sherb as interim Chief Financial Officer brings an experienced CPA with 16 years of expertise in financial reporting, auditing, and capital markets, including SEC and PCAOB compliance.
• Mr. Sherb's background includes successful assistance with IPO and audit readiness, registration statement filings, and coordination with various stakeholders, which could provide stability during this transition.

Negatives

• The simultaneous resignations of the Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer on the same day (October 6, 2025) indicate significant and abrupt leadership instability.
• The departure of three top executives creates a substantial leadership vacuum and raises concerns about the company's operational continuity and strategic direction.

Risks

• **Leadership Vacuum and Instability:** The simultaneous departure of the CEO, COO, and CFO creates a significant leadership void and raises concerns about the company's stability and future direction.
• **Operational Disruption:** The transition period for key executive roles could lead to operational inefficiencies, delays in decision-making, and potential disruption to ongoing projects.
• **Investor Confidence:** Such widespread executive turnover can negatively impact investor confidence, potentially leading to stock price volatility.
• **Strategic Uncertainty:** The absence of permanent top leadership may lead to uncertainty regarding the company's strategic initiatives and long-term plans.
• **Integration Risk for Interim CFO:** While experienced, an interim CFO may not have the same long-term commitment or deep institutional knowledge as a permanent executive, potentially affecting strategic financial planning.

Future Outlook

The filing does not provide any explicit forward-looking statements or guidance regarding the company's future performance or strategic direction. It primarily reports on executive changes.

Industry Context

Significant executive turnover, particularly the simultaneous departure of a CEO, COO, and CFO, is generally viewed negatively across industries. It often signals internal challenges, strategic shifts, or governance issues. While the appointment of an experienced interim CFO can mitigate some immediate concerns, the broader context suggests a period of potential instability for Wellgistics Health, contrasting with industry trends that favor stable and consistent leadership for strategic execution and investor confidence.

Comparison to Industry Standards

• The simultaneous resignation of a CEO, COO, and CFO is an unusual and significant event, far exceeding typical executive turnover rates seen in stable, publicly traded companies.
• Companies like Johnson & Johnson or Pfizer typically manage executive transitions with clear succession plans and staggered departures to ensure continuity, minimizing leadership gaps.
• The immediate appointment of an interim CFO, while necessary, highlights the abrupt nature of these departures, suggesting a more disruptive event than standard industry practice.

Management Changes

Related Party Transactions

• The Company entered into a Consulting Agreement with EMS Consulting Services, Inc., an entity controlled by Eric Sherb (the newly appointed interim CFO), on September 8, 2025. This agreement was amended to reflect Mr. Sherb's role as interim CFO.

Stakeholder Impact

• **Shareholders:** Likely negative impact due to significant leadership instability, potential for stock price volatility, and uncertainty regarding future strategic direction.
• **Employees:** Potential for uncertainty, morale issues, and concerns about job security or company direction due to the departure of top executives.
• **Customers/Suppliers:** Possible concerns about continuity of operations, service delivery, or business relationships during a period of executive transition.
• **Creditors:** May raise questions about the company's financial stability and ability to meet obligations, especially if the leadership vacuum persists.

Next Steps

• The company will need to identify and appoint permanent replacements for the Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer.
• The interim CFO, Eric Sherb, will perform various financial services typical of a CFO for a publicly-traded company.

Key Dates

Recommendation

The simultaneous resignation of the CEO, COO, and CFO is a severe indicator of internal turmoil and leadership instability. This level of executive exodus typically signals significant underlying problems, creating immense uncertainty about the company's operational continuity, strategic direction, and future performance. While an interim CFO has been appointed, the lack of permanent leadership in critical roles, especially CEO and COO, makes the company highly vulnerable. Investors should consider selling to mitigate exposure to potential further declines and prolonged instability until a clear, stable leadership team and strategic vision are established.

Keywords

Wellgistics Health, WGRX, Executive Resignations, CEO Resignation, COO Resignation, CFO Resignation, Interim CFO, Eric Sherb, Management Change, Corporate Governance, Financial Reporting, Nasdaq Capital Market, SEC Filing, 8-K